AstraZeneca's Imfinzi Meets Endpoint in Lung Cancer Study

AstraZeneca's Imfinzi Meets Endpoint in Lung Cancer Study - Nasdaq

- June 28, 2019

AstraZeneca's Imfinzi Meets Endpoint in Lung Cancer Study Nasdaq

AstraZeneca Plc AZN announced positive overall survival (OS) results from the phase III CASPIAN study evaluating Imfinzi (durvalumab) in first-line ...

Search This Blog

Lung Cancer

AstraZeneca's Imfinzi Meets Endpoint in Lung Cancer Study - Nasdaq

Comments

Post a Comment

Popular posts from this blog

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago

Not An Ordinary Cough: Lung Cancer Symptoms That You Might Neglect - International Business Times

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago